FormFactor (FORM) Investor presentation summary

Market position and industry trends

• Holds leadership in the semiconductor test and measurement sector, recognized for technology and quality by industry leaders and customers worldwide.

• Benefits from secular trends such as exponential semiconductor content growth, AI, data center expansion, and advanced packaging adoption.

• Maintains strong relationships with major semiconductor manufacturers, earning top supplier awards and consistent high rankings for customer service and product performance.

• Early customer engagement and largest R&D budget in served markets create high barriers to entry and sustain competitive advantage.

• Unique position across the semiconductor value chain, with significant presence in both advanced probe cards and engineering systems.

Financial performance and growth

• Achieved $840M trailing twelve-month revenue as of April 2026, with a workforce of approximately 2,100 people.

• Demonstrated a proven track record of revenue growth, expanding gross margins, and increasing free cash flow over recent years.

• Targeting $850M in revenue and $2.00 non-GAAP EPS in its financial model, with significant operating leverage and margin expansion.

• Q1 2026 delivered record revenue and exceeded outlook for gross margin and EPS; Q2 2026 outlook projects continued strong demand, especially in DRAM and data center CPU applications.

• Maintains a resilient business model with flexible cost structure, strong free cash flow, and a healthy balance sheet supported by a new $150M revolving credit facility.

Strategic initiatives and capital allocation

• Pursues growth through organic investment in R&D, capacity expansion, and disciplined M&A, focusing on market leaders and complementary technologies.

• Acquisition strategy has added scale and diversification, with successful integrations of several companies and product lines since 2012.

• Capital expenditures support organic growth, including new manufacturing centers and automation, with a target CapEx of 3.5–4.0% of revenue.

• Scale enables margin enhancement and funds differentiating R&D, driving new organic growth opportunities.

• Stock buybacks are used to offset dilution from stock-based compensation.